Rare diseases
Investigational molecules
Locations
Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
FranceStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
FranceLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
FranceStudy on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease
FranceStudy on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis
FranceStudy on the Safety and Effects of Tulisokibart for Patients with Moderate to Severe Crohn's Disease
FranceStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
FranceStudy on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma
FranceStudy on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels
FranceStudy of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease
FranceStudy on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
